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inhibitor Y27632. Matrix production was estimated by sulfate in-
corporation normalized to DNA. Phospho-cofilin was assayed by
SDS-PAGE of cell lysates and immunobloting.
Results: To determine whether TGFb affects actin dynamics via
the actin depolymerizing factor cofilin, we tested cofilin phos-
phorylation after TGFb treatment. Cofilin is rendered inactive by
phosphorylation, resulting in decreased actin filament stability.
TGFb induced a transient decrease in phospho-cofilin after 5
and 20 minutes, which recovers to near-basal levels after 1 hour.
ROCK inhibitor caused a substantial and persistent decrease
in phospho-cofilin independent of TGFb treatment. Total cofilin
remained unchanged, indicating that the pathway was controlled
by phosphorylation.
To determine whether the ROCK pathway is important for the
anabolic effects of TGFb[[Unsupported Character - &#61484;]]
we measured chondrocyte matrix synthesis. TGFb-induced ma-
trix synthesis was significantly inhibited by the ROCK inhibitor
Y27632, but Y27632 alone did not affect sulfate incorporation.
Chondrocytes isolated from older cartilage showed both a dimin-
ished overall sulfate incorporation rate and a decreased anabolic
stimulation by TGFb.
Conclusions: Cofilin is a major determinant of F-actin stability.
We showed that basal cofilin phosphorylation requires active
ROCK in chondrocytes. TGFb caused a transient increase in
cofilin activity, predicting active remodeling of the actin cytoskele-
ton. Phospho-cofilin returns to basal levels in an hour, indicating
stabilization of the remodeled F-actin structures. Extended TGFb
treatment does not induce matrix synthesis in the presence of
ROCK inhibitor. It is therefore likely that the inactivation of cofilin
downstream of ROCK and the ensuing stabilization of F-actin
are required for the anabolic activity of TGFb. We are investigat-
ing whether age-related changes in the activation of the ROCK
pathway may explain the reduced anabolic response to TGFb.
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Purpose: Mechanical forces regulate chondrocyte proliferation,
survival, differentiation, gene expression, and biosynthetic re-
sponses. The type of mechanical stimulation determines the
cellular responses, which range from proliferation to death and
from matrix formation to destruction.
Mechanotransduction pathways in chondrocytes that recognize
applied forces and elicit the appropriate biochemical responses
are not well characterized. A current theory is that actin cy-
toskeleton provides a framework onto which mechanosensation
mechanisms are assembled. The cytoskeleton links to the ex-
tracellular matrix at focal adhesions, which help convert external
physical forces into signal transduction events.
The Rho GTPases affect actin structures, and enhance focal
adhesion formation. A major effector pathway downstream of Rho
is the activation of Rho Kinase (ROCK), which phosphorylates
and activates Lim Kinase, which in turn phosphorylates and
inhibits the actin-depolymerizing protein cofilin.
The purpose of this study was threefold: 1) quantify the actin
reorganization in response to dynamic compression (DC) of
agarose-embedded chondrocytes. 2) test if Rho Kinase is re-
quired for the DC-induced actin reorganization. Third, to test
if DC alters localization of Rho Kinase and actin remodeling
proteins.
Methods: Chondrocytes were harvested from human articular
cartilage by collagenase digestion and passaged once. Cells
were cultured embedded in 3% agarose for 7-10 days, then
serum-starved 24hrs. Dynamic compression (5-15% sinusoidal
strain, 0.5Hz) was applied 19 hours, +/- ROCK inhibitor (50uM
Y27632). After formaldehyde fixation and acetone permeabliza-
tion actin was stained with phalloidin-Alexa488, nucleus with
ToPro3. Antibodies recognizing phospho-ROCK, phosphoFAK
and cofilin were visualized with anti-rabbit-Alexa546. Confocal
analysis was on a Zeiss LSM510 with 63x objective.
Quantitation of actin volume, cortical thickness, peripheral pro-
cesses, and central punctuate spots was done with custom
MatLab program. The program identifies the cortical actin shell
and counts cytosolic punctuate actin spots using thresholding
to segment the image into binary objects. Additional analysis
includes "actin volume" from the total number of F-actin pos-
itive pixels. The distance of each positive pixel to the cortical
actin shell is used to estimate cortical thickness and peripheral
processes. Repeated experiments and student’s t-test (p<.05)
establish significance.
Results: Dynamic compression (DC) of agarose-embedded
chondrocytes induced actin cytoskeletal remodeling, as mea-
sured and quantified using image analysis program. DC sig-
nificantly increased punctate actin structures. ROCK activity is
required for these cytoskeletal changes, as DC in the presence
of ROCK inhibitor did not induce punctate actin structures. DC
increased the amount of phospho-ROCK seen with immunofluo-
resce microscopy.
Conclusions: Chondrocytes respond to moderate dynamic com-
pression by increased matrix synthesis. The signal transduction
pathways that mediate this are not yet fully characterized, but
they are likely to involve the actin cytoskeleton. We quantify DC-
induced changes in the actin cytoskeleton of agarose-embedded
chondrocytes. Furthermore, we show that ROCK is required for
this actin reorganization. In support of this, we show that ROCK
is phosphorylated during DC. Ongoing research will determine
whether the Rho Kinase-dependent cytoskeletal reorganization
is required for the altered gene expression and increased matrix
production that is induced by DC.
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Purpose: To investigate the effect of hyaluronan (HA) molecular
weight (MW) on interleukin-1 (IL-1)-induced production of matrix
metalloproteinases (MMPs) and loss of proteoglycans (PG) from
chondrocytes and cartilage explants respectively.
Methods: Preparation of HA with Different MW: HA was depoly-
merized by gamma irradiation of sterile, dry HA (bacterial source,
3.0 MDa) powder to give samples of HA with MWs of 0.1, 0.49,
0.72 and 1.6 MDa while 0.005 MDa HA was prepared by enzy-
matic degradation.
Cartilage Explant: Bovine cartilage explants (60-80 mg) were
equilibrated in DMEM for 24 hours, then treated with HA (1.0-3.0
mg/mL and 0.005-3.0 MDa) either for 24 hours before (prophy-
lactic conditions) or 24 hours after (therapeutic conditions) stimu-
lation with IL-1α (5 ng/ml). Dimethylmethylene blue (DMMB) and
safranin-O staining was performed to determine proteoglycan
content.
Harvest and Chondrocyte Culture: Human chondrocytes were
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Fig. 1. Larger molecular weight HA (1.6 and 3.0 MDa) inhibits active MMP-3 and MMP-13 while lower molecular weight HA (0.005, 0.1 and 0.49 MDa) effects MMP-3
activity only. *p-value < 0.05.
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isolated from cartilage (NDRI, Philadelphia, PA) by sequential
digestion with collagenase and cultured in monolayer(s) using
DMEM.
MMP Assays: Chondrocyte monolayer cultures were pretreated
with different amounts of HA (0.5 - 3.0 mg/ml) for 2 hours followed
by IL-1β stimulation for 24 hours. Supernatants were collected
and assayed by commercially available ELISA for MMP-1 and
-13 (R&D systems, Minnesota, MN) and MMP-3 (Amersham
Biosciences, Piscataway, NJ). RNA was isolated from cells for
real time PCR analysis of MMP-1, 3, -13 and GAPDH.
IL-1 Binding Studies: These studies were performed by
MDS/Pharma Services, Seattle, WA.
Statistical Analysis: Student’s paired t test (SigmaPlot 9.0, Rich-
mond, CA) was used to determine the level of significance (p <
0.05).
Fig. 2. Larger molecular weight HA (3.0 MDa) inhibits production of total MMP-3 and MMP-13 while lower molecular weight HA (0.1 MDa) effects total MMP-3
production only. CMC had no effect on IL-1β induced MMP production in human chondrocytes. *p-value < 0.05.
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Results: Bovine Explant Culture: HA (0.72 and 3.0 MDa) in-
hibited in a dose dependent manner the IL-1-induced loss of
PG under both prophylactic and therapeutic conditions as deter-
mined by GAG and histological assays. Low molecular size HA
(5 kDa) alone induced PG loss confirming its previously reported
chondrolytic activity.
Chondrocyte Monolayer Culture: HA of all molecular sizes in-
hibited MMP-1 and MMP-3 in dose- and molecular weight-
dependent manners at both the protein and RNA level. However,
only the higher MWs of HA (1.6 and 3.0 MDa) inhibited MMP-13
production (Figure 1). This HA inhibition was not due to a poly-
electrolyte effect since sodium carboxymethyl cellulose (CMC)
had no effect on IL-1 induced MMP production (Figure 2).
IL-1 Binding Studies: IL-1 Receptor binding studies showed that
the HA did not inhibit IL-1β binding to its receptor.
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Conclusions: These data indicate that HA, irrespective of its
molecular size, inhibits the production of mRNA for MMP-1 and
-3 in monolayer chondrocyte culture. However, only the 1.6 and
3.0 MDa HA inhibited mRNA and protein production for MMP-13.
This MW dependence on MMP inhibition is consistent with the
ability of higher MW HA to bind to multiple CD44 receptors on the
cell surface thereby resulting in a more robust down regulation of
MMP. Furthermore, MMP inhibition at transcriptional level and ab-
sence of HA interaction with IL-1 receptor binding suggests that
HA modulates MMP production indirectly from the IL-1 receptor.
In addition, 0.1, 0.72 and 3.0 MDa HA prevented proteoglycan
loss in bovine explant cultures. These in vitro culture systems
suggest that high MW HA is potentially more chondroprotective
in the treatment of osteoarthritic joints.
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Purpose: To investigate the presence and functionality of es-
trogen receptor alpha (ERα) in IL-1β-treated rabbit articular
chondrocytes in culture. To determine the mechanisms of 17β
estradiol (E2) effects on IL-1β-induced iNOS expression.
Methods: The presence and functionality of ERα were investi-
gated by immunocytochemistry and transient expression of an
E2-responsive reporter construct. iNOS expression and produc-
tion were determined by transient expression of a chimeric iNOS
promoter-luciferase construct and protein immunoblotting. NO
production was determined by the Griess reaction. DNA binding
activities of NF-kB and AP-1 were determined by EMSA-Elisa
assays. Nuclear translocation of p65 was studied by immunocy-
tochemistry.
Results: ERα was identified in the nucleus of chondrocytes. ERα
efficiently transactivated a transiently expressed E2-responsive
construct. Upon IL-1β treatment, ERα partially diffused from its
nuclear localisation into the cytoplasm and its transactivation
ability was impaired. Nevertheless, E2, Tamoxifen and Raloxifen
efficiently inhibited IL-1β induced NO production (-34%, -31% and
-36% respectively). E2 decreased IL-1β induced iNOS protein
expression (-40%). Transient expression of an iNOS promoter
construct strongly suggested that iNOS expression was inhibited
at the transcriptional level and EMSA-ELISA assays showed that
E2 reduced (-60%) the IL-1β induced p65 DNA binding capacity.
Finally, the p65 nuclear translocation induced by IL-1β was also
strongly decreased by E2.
Conclusions: Our data support a reciprocal antagonism be-
tween estrogens and IL-1β ultimately resulting in the decrease of
cytokine-dependent NO production through transcriptional inhibi-
tion of iNOS expression. This effect was correlated with selective
inhibition of p65 DNA binding and nuclear translocation.
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Purpose: We have previously shown that Interleukin-1β (IL-
1β), which plays crucial role in osteoarthritic cartilage break-
down, impairs TGFβ signaling through TβRII down-regulation
and secondarily Smad7 up-regulation. These effect could ex-
plain the reduced responsiveness of OA chondrocytes to TGFβ
and degradative process. The aim of this present study was to
investigate the mechanism of IL-1β induced down-regulation of
TβRII in Human Articular Chondrocytes (HAC).
Methods: mRNA and protein half-lifes were determined, using
transcription and translation inhibitors. Then, the protein degra-
dation mechanism and signalling pathways implicated were in-
vestigated, using specific inhibitors (proteasome, MAPK, ...).
Transient transfections of human TβRII promoter constructs were
performed to delineate the DNA sequences that mediate IL-1β
transcriptional effect. Experiments were also done to overexpress
or inhibit transcription factors involved in that regulation.
Results: IL-1β decreases TβRII protein half-time and reduces
gene transcriptional activity. The effect on TβRII gene expression
is mediated through the core promoter (-47/-15 bp) that contains
putative binding site for Sp1, and involves both NFκB and JNK
pathways. Experiments of gain/loss of function for p65, Sp1 and
Sp3 indicate that these transcription factors cooperate to induce
TβRII repression. Furthermore, IL-1β effects are dependent of
acetylation and methylation processes.
Conclusions: These findings enlighten the regulatory process
of IL-1β on TβRII expression. Understanding the molecular basis
for IL-1β reduction of TβRII expression provides news insight into
molecular mechanisms of OA and may facilitate identification of
novel approaches for its treatment.
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Purpose: Cartilage lubrication and intensity of free-radical pro-
cesses in joint tissues play a crucial role in the joint functioning.
Mechanisms which provide adequate biological lubrication and
maintenance of physiological level of free-radical processes in
the joints are not established yet. We have studied some bio-
chemical and lubricating properties of bone marrow fat in the
assumption of its participation in joint lubrication.
Methods: Stability of cruciate ligaments to cyclic loadings was
investigated on preparations of human knee joints. The bone
marrow fat was produced by compression of the retrieved can-
cellous bone after joint replacement and the subsequent centrifu-
gation. The main lipid classes of human bone fat were identified
by thin-layer chromatography. The concentration of antioxidants
in bone fat was determined using the model reaction of initiated
oxidation of cumene. The lubricating property of biological fluids
was tested for using a tribometer and a "polyethylene-stainless
steel" or "cartilage-on-cartilage" friction pair.
Results: In experiments on preparations of human knee joints it
was revealed that cyclic loading on ligamentous structures leads
to the occurrence of an oily transsudate in a joint cavity. We
